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Abstract
Background:  Stable transgenesis is an undeniable key to understanding any genetic system.
Retrovirus-based insertional strategies, which feature several technical challenges when they are
used, are often limited to one particular species, and even sometimes to a particular cell type as
the infection depends on certain cellular receptors. A universal-like system, which would allow
both stable transgene expression independent of the cell type and an efficient sorting of transfected
cells, is required when handling cellular models that are incompatible with retroviral strategies.
Results: We report here on the combination of a stable insertional transgenesis technique, based
on the Tol2 transposon system together with the magnetic cell sorting (MACS) technique, which
allows specific selection of cells carrying the transgene in an efficient, reliable and rapid way.
Conclusion: This new Tol2/MACS system leads to stable expression in a culture of primary
chicken erythroid cells highly enriched in cells expressing the transgene of interest. This system
could be used in a wide variety of vertebrate species.
Background
Transient and stable transgenesis is a powerful and funda-
mental technique for understanding any genetic system.
In particular, integration in the genome, which allows for
the stable expression of a transgene, is often a prerequisite
for studying the biological function of a gene.
Retrovirus-based insertional strategies, the technique
most frequently used to obtain stable transgenesis,
present some technical drawbacks. First, following inser-
tion, the presence of viral sequences can lead to the trans-
activation of nearby cellular genes through the action of
strong enhancer/promoter elements contained, for exam-
ple, within the viral long terminal repeat (LTR) [1-4]. Also,
the handling and modification of retroviral vectors is
laborious and time-consuming. Finally, since these strate-
gies are based on an infection process, they depend on cel-
lular receptors [5] so their use is limited to a particular
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species, and sometimes even to a particular cell type. This
latter restriction is perhaps the main one when handling a
particular cell type or samples from a particular (less com-
monly used) species, incompatible with retroviral strate-
gies.
To circumvent these problems, a novel method of trans-
genesis, using a transposon-mediated gene transfer tech-
nique, has been recently described (see references below).
Transposons are genetic elements that can move from one
locus in the genome to another and they have been used
as powerful tools in model animals and plants. The Tol2
transposable element, which was originally found in the
medaka fish [6], has been reported to be capable of under-
going efficient transposition in a wide variety of vertebrate
species including zebrafish, frog, mice, chicken and
human [7-12]. Recently, cis-sequences necessary for the
Tol2 element transposition were revealed [13] which led
to the development of transposon vectors containing
minimal DNA sequences that are easily manipulated. A
plasmid, harboring a Tol2 construct with the gene expres-
sion cassette flanked by Tol2 cis-sequences, and a helper
plasmid, containing the transposase-coding sequence
driven by a constitutive promoter, are simultaneously
introduced into vertebrate cells. As a result of the trans-
posase activity, the transposon construct is excised from
the plasmid, and subsequently integrated into the host
genome ([14], see also Figure 1A).
As the use of the chicken model expands [15], efficient
and stable transgenesis methods in this species are
increasingly required for many experimental strategies,
including genetic screens and dissection of transcriptional
regulatory networks. In addition to being a remarkably
important and historic model system in developmental
biology, genomic resources for Gallus gallus, including the
genomic sequence [16], have been expanding rapidly.
Moreover, G. gallus is an interesting source of primary cells
for large-scale ex-vivo studies, such as the normal erythroid
progenitors T2EC (called for TGF-α/TGF-β-induced Eryth-
rocytic Cells) [17]. A transcriptomic approach in T2EC has
allowed for the identification of a group of candidate
genes important for normal or pathological self-renewal
[18-20]. Downstream of these genomic approaches, it is
now essential to be able to perform functional studies tar-
geting those candidate genes in order to understand their
biological role, for example in the self-renewal process, by
acquiring a stable expression of their corresponding
cDNAs in a significant proportion of cells among the total
population.
We describe here the use of a Tol2-mediated stable gene
transfer in primary chicken erythroid progenitors. In order
to obtain a significant proportion of cells expressing the
gene of interest within the total population, we have asso-
ciated this Tol2-based transgenesis with the MACS (MAg-
netic Cell Sorting) system ([21], see also Figure 1B). We
demonstrate that the resulting Tol2/MACS system allows
the enrichment of the cell population in cells that stably
express the transgene, reported here by the eGFP.
Methods
Plasmid constructs
pT2MIK (6.7 kb, Figure 1C): pT2AL200R150G [13] was
digested with XhoI/BglII to remove the cassette containing
the EF1α promoter-eGFP-polyA sequence. These sites
were blunt-ended, and the blunt-ended fragment CMV-
MCS-IRES-ΔhCD4-polyA, prepared by NruI/XhoI diges-
tion from pMACS-4-IRES.II [21], was inserted. The
pT2MIK plasmid obtained permits the expression of a
bicistronic mRNA controlled by a constitutive promoter
(CMV). It harbors a MCS to clone the gene of interest, fol-
lowed by the ΔhCD4-coding sequence, which is down-
stream of an IRES to allow its translation.
pT2MIK-eGFP (7.6 kb, Figure 1C): the pT2MIK plasmid
was digested with EcoRV, a site present in the MCS. A
blunt-ended ClaI fragment from pRCAS.C-EGFP (kindly
donated by Pr. Germain Gillet), containing the eGFP cod-
ing sequence, was then inserted.
pCAGGS-T2TP (7 kb, Figure 1A) [10]: transposase sup-
plier plasmid that contains the transposase cDNA driven
by the strong CAGGS promoter (a modified CMV). A tran-
sient supply of the CAGGS-controlled transposase
appears to be sufficient for the transposition of a trans-
fected gene, as shown below. Moreover, it is assumed that
the transient activity of transposase avoids an unnecessary
repetition of transposition once the cassette has been inte-
grated into the genome.
pT2.CMV-hKO  (5.1 kb, see Additional File 1):
pT2AL200R150G [13] was digested with XhoI/BamHI to
remove the cassette containing the EF1α promoter. These
sites were blunt-ended, and the blunt-ended fragment
containing the CMV promoter, prepared by HindIII/XbaI
digestion from the pCRNCM plasmid [22], was then
inserted. The eGFP fragment was subsequently removed
by ClaI digestion, and a ClaI fragment containing hKO,
previously extracted from phKO1-S1 (MBL International
Corporation) by a BamHI/HindIII digestion, was inserted.
Primary cell culture
T2EC cells were generated from SPAFAS white leghorn
chickens (PA12 line from INRA, Tours, France) as previ-
ously described [17]. These cells were expanded in LMI
medium (α-MEM medium, 10% FBS (Fetal Bovine
Serum), 1 mM Hepes, 100 nM β-mercaptoethanol, 1 mM
dexamethasone, 5 ng/ml TGF-α, 1 ng/ml TGF-β1, 100 U/
ml penicillin and 100 μg/ml streptomycin).BMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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Cell transfection by nucleofection
Transient transfections were performed by the nucleofec-
tion method (Amaxa Technology). For each nucleofection
assay, 107 cells were washed once with PBS and resus-
pended in 100 μl of nucleofector buffer (Cell line Nucle-
ofector kit V, Amaxa/Lonza). After adding 10 μg of DNA
(pT2MIK or pT2MIK-eGFP +/- pCAGGS-T2TP in variable
molecular ratios), cells were transferred to the cuvette sup-
plied and nucleofected with the T-16 program of the
Nucleofector device (Amaxa/Lonza). Following nucleo-
fection, cells were immediately transferred to LM2
medium (LM1 medium with RPMI 1640 instead of α-
MEM) and grown overnight (18 hours maximum).
Magnetic Cell Sorting (MACS)
To increase the MACS efficiency, dead cells and fragments
were removed before each MACS assay. For this, living
cells were purified by centrifugation through a density gra-
dient on LSM (Lymphocytes Separation Medium, Euro-
bio) to get rid of any dead cells and cellular fragments. Up
to 107 cells were resuspended in 1 ml of LM1 and carefully
laid onto 1 ml of LSM. After a 15 minute centrifugation at
2500 rpm without brake, the cells on top of the LSM were
recovered, washed with 3 ml of PBSA (PBS, BSA 0.5%)
and resuspended in PBSA.
Stable Transgenesis and Sorting Systems Figure 1
Stable Transgenesis and Sorting Systems. A: Tol2 transposition system: Cells are cotransfected with the plasmid carry-
ing the Tol2 construct (Expression plasmid) and the helper plasmid, allowing a transient transposase expression (pCAGGS-
T2TP). On the one hand, the Tol2 construct contains the expression cassette that should be integrated in the cellular genome, 
flanked by two Tol2 cis-sequences. On the other hand, the helper plasmid contains the transposase cDNA driven by a CAGGS 
promoter (a CMV-based constitutive promoter). The Tol2 construct is transposed by a cut-and-paste mechanism that requires 
the sequence-specific binding of the transposase to the Tol2 sequences on each extremity of the cassette. This transposition 
process involves the precise excision from the plasmid and integration of the cassette into the genomic DNA. B: Magnetic Cell 
Sorting (MACS): Cells are transfected with a plasmid construct harboring both the transgene and the ΔhCD4-coding sequence. 
The ΔhCD4 is a surface marker, derived from the human CD4 in which the cytoplasmic region was deleted. Positive cells, 
expressing both transgene and the ΔhCD4 marker, are magnetically labeled with an antibody, coupled to metallic microbeads, 
which recognizes the hCD4 extracellular region. After passing the heterogeneous cell population through a column placed on 
a magnetic field, labeled cells are retained by the column, whereas negative cells pass through. Positive cells are then easily 
eluted by just moving the column away from the magnet. C: The engineered pT2MIK empty plasmid with a multicloning site 
(MCS) and the pT2MIK-eGFP plasmid used throughout this study.BMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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Transfected cells, co-expressing the ΔhCD4 marker on the
cell surface (Figure 1B), were then magnetically isolated
and separated from untransfected cells using the MACSe-
lect - Transfected Cell Selection System. Up to 107 cells
were magnetically labeled with the MACSelect
MicroBeads and separated on a MACS Column and an
OctoMACS Separator by magnetic force. The sorting was
performed according to the manufacturer's instructions,
with the following modification: PBSA (PBS, BSA 0.5%)
was used instead of PBE (PBS, EDTA 5 mM).
Immunofluorescent hCD4 staining
106 cells were labeled with a human CD4 antibody conju-
gated to allophycocyanin (APC) fluorochrome (CD4-APC
Miltenyi Biotec) according to the manufacturer's instruc-
tions, with the following modification: no EDTA was
added to the staining buffer.
Flow cytometry analysis
Fluorescence data was acquired with a FACSCanto II flow
cytometer and the data was analyzed using the 5.0.1 Diva
software (both from Becton-Dickinson). The positive flu-
orescence threshold was fixed in order to have 99% of the
negative cells below this threshold.
Statistical Analysis
Firstly, in order to determine whether performing a para-
metric test was possible or not, the homoscedasticity of
the distribution (homogeneity of variance) was tested
using a Fischer-based test (O'Brien test). In our case, as
values were homoskedastic for all the comparisons, only
parametrical tests were then used. When comparing only
one pair, a Student test (t-test) was applied. When com-
paring simultaneously three conditions or more, signifi-
cant differences among the compared conditions were
first tested by an ANOVA (Analysis of Variance). For a sig-
nificant ANOVA test, all pairs' comparison was tested
using the Tukey-Kramer HSD test.
Genomic insertion sites identification by the splinkerette 
PCR technique
Transfection and stably transfected monoclonal T2EC cells
To identify the T2EC Tol2 genomic insertion site, we used
a simplified pT2MIK-derived plasmid (pT2.CMV-hKO)
expressing the CoralHue humanized Kusabira-Orange flu-
orescent protein reporter (MBL International Corpora-
tion) driven by the CMV promoter. As described above, 5
× 106 cells were nucleofected with 5 μg of plasmid DNA
(pT2.CMV-hKO/Transposase = 5/1). Eight days after
transfection, cells expressing the reporter gene were sorted
and individually cloned in conical bottom 96-well micro-
plates using a FACSVantage SE cytometer (Becton-Dickin-
son). Two clones were grown for 13 days, by which time
the clonal population size was 2.8 × 105 and 4 × 105 cells,
prior to DNA extraction.
Genomic DNA extraction, restriction endonuclease digestion and 
splinkerette adaptor ligation
Each of the two clones was lysed in STE buffer (100 mM
NaCl, 1 mM Na2-EDTA pH 7.8, 10 mM Tris-HCl pH 8) for
1 hour, at 50°C, in the presence of SDS and Proteinase K
(Roche). Genomic DNA (gDNA) was then treated for 20
min at 60°C with RNase A (Sigma-Aldrich) before being
purified with 1 volume phenol/chloroform/isoamyl alco-
hol (25:24:1, v/v/v) (Sigma-Aldrich) and precipitated
with 2 volumes of absolute ethanol and 1/9th volume of 3
M NaOAc pH 5.2. Subsequently, 1 μg of gDNA was
digested with 1 μl of FastDigest TaiI (Fermentas), the rec-
ognition site of which is a 4 bp motif, for 16 hours at
65°C. This digestion was performed using the Fermentas
10× FastDigest buffer, in a final volume of 20 μl.
Considering that a 4 bp recognition site will occur roughly
every 256 bp, and therefore that 200 ng of TaiI-digested
gDNA correspond to 1.28 pmol DNA, 200 ng of digested
DNA were ligated to a 3× molar excess of the annealed
splinkerette adaptor (Splinklong-ACGT+Splinkshort-hair-
pin) with the T4 DNA ligase (4 U), for 1 hour at 22°C,
using the Fermentas Rapid DNA Ligation kit. In order to
improve the ligation yield, digested DNA was heated for 5
min at 60°C before being ligated.
Finally, the ligation product was purified with phenol/
chloroform/isoamyl alcohol following the same protocol
as for the gDNA extraction and using glycogen (Fermen-
tas), at a final concentration of 1 μg/μl, in a total volume
of 20 μl.
This procedure was also performed for the pT2.CMV-hKO
plasmid and for non-transfected T2EC gDNA to obtain,
respectively, positive and negative controls of splinkerette
PCR.
Adaptor and primers
The splinkerette adaptor and the oligonucleotide primers
used for this study were synthesized by Invitrogen and are
identified as follows:
Splinklong-ACGT: CGAAGAGTAACCGTTGCTAGGAGA-
GACCGTGGCTGAATGAGACTGGT GTCGACACTAGT-
GGACGT.
Splinkshort-hairpin: CCACTAGTGTCGACACCAGTC TCT
AATTTTTTTTTTCAAAAAAA.
hKOSp1: AGACCGAGGGCAACATCACCGAGC.
Splink1: CGAAGAGTAACCGTTGCTAGGAGAGACC.
nested-hKOSp2: GTGGAGGACGCCGTGGCCCACTGC.
nested-Splink2: GTGGCTGAATGAGACTGGTGTCGAC.BMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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Splinkerette PCR
Two rounds of PCR (PCR1 and nested-PCR2), using prim-
ers specific for the reporter transgene hKO (hKOSp1 and
nested-hKOSp2) and for the annealed splinkerette adap-
tor (Splink1 and nested-Splink2), were performed with
the AccuPrime Taq DNA Polymerase High Fidelity (Invit-
rogen), in a final volume of 50 μl (AccuPrime PCR Buffer
II 1×, 200 nM Forward Primer, 200 nM Reverse Primer, 1
U AccuPrime Taq DNA Polymerase). The PCR DNA tem-
plate was 1/300th of the ligation product for the PCR1 and
1/10th of the PCR1 product for the nested-PCR2.
The two PCR rounds were run in a Biometra TRIO-Ther-
moblock (Biometra) using the following program: 2 min
of initial denaturation at 94°C, followed by 30 cycles of
30 s denaturation at 94°C, and 4 min of annealing-elon-
gation at 68°C.
PCR products were then loaded onto 25 cm × 25 cm 1.5%
agar gel and purified using the NucleoSpin Extract II
(Macherey-Nagel), according to the manufacturer's
instructions.
DNA sequencing and analysis
DNA sequencing was performed with an ABI PRISM
3100-Avant Genetic Analyzer, according to the instruc-
tions of the BigDye Terminator v1.1 Sequencing kit
(Applied Biosystems). The Tol2 insertion sites in T2EC
gDNA were identified by alignment with the ENSEMBL
database http://www.ensembl.org using the BLASTN algo-
rithm.
Results
The Tol2 construct allows for stable transgene expression 
in primary cells
We first tested the possibility of generating stable trans-
fectants in T2EC cells using the Tol2 system. For this,
T2EC were transfected by nucleofection using the
pT2MIK-eGFP plasmid (Figure 1C), either in the absence
(eGFP) or in the presence (eGFP+T) of the transposase
expression plasmid (Figure 2A), and fluorescence was
recorded as a function of time. It was immediately appar-
ent that in the absence of transposase, as expected, no flu-
orescence was detected one week after transfection. This is
in marked contrast to the cells cotransfected with the
transposase-supplier plasmid (in equimolar amounts of
both plasmids) where 10.0% ± 1.7 of cells within the total
population retained eGFP signals for up to 14 days (Figure
2A).
In order to determine optimal cotransfection conditions,
we tested different molar ratios of the plasmid carrying the
gene of interest and of the helper plasmid. We, thus,
observed that the efficiency of stable expression is higher
when there is more pT2MIK-eGFP expression plasmid
than transposase-supplier helper plasmid (Figure 2B).
Indeed, when adding 5 times less eGFP expression plas-
mid than transposase expression plasmid (1/5 ratio), only
4.0% ± 1.0 of cells expressed eGFP after one week.
Equally, we observed that equimolar conditions (1/1
ratio) increased this percentage (i.e. 10.0% ± 1.7),
although this difference is not statistically significant.
Inversing the ratio, and adding more eGFP expression
plasmid than the transposase one, ultimately leads to a
significantly higher proportion of eGFP-positive cells:
11,0% ± 2.1 and 12.5% ± 4.3 for 5/1 and 10/1 ratios,
respectively. After two weeks, although the differences
seem not to be important because of a significant standard
deviation (often observed in primary cultures as cells
become senescent), the tendency remains the same.
Our data, therefore, demonstrates that the molecular ratio
between the Tol2 plasmid and the transposase helper
plasmid has an impact on the stable expression efficiency
in T2EC. Efficacy is certainly improved when adding
higher amounts of the Tol2 construct plasmid than the
transposase provider plasmid. The 5/1 ratio leads to an
optimal level of expression of the gene of interest, with
about 10% of the transfected cells stably expressing the
reporter transgene.
The transgene carried by the Tol2 construct is stably 
transposed into the cellular genome
Our results strongly suggest that transposition into the
genomic DNA (gDNA) was successfully achieved. To con-
firm this hypothesis, we identified the transgene insertion
sites in two T2EC clones transfected with a Tol2 construct,
using a modified version of the splinkerette PCR tech-
nique [23]. After sequencing the corresponding PCR frag-
ment (Figure 3A) and identifying the Tol2 construct, we
aligned all of the "non-Tol2" region sequence with the G.
gallus gDNA sequence (Figure 3B). We observed that, in a
clonal population, there seems to be only one single inser-
tion point, which is located in chromosome 4 (Figure 3C).
The second T2EC clone analyzed also shows one single
insertion point, localized in a different chromosome
(chromosome 1; see Additional File 2).
The cotransfection of the expression plasmid, together
with the transposase-supplier helper plasmid, has there-
fore allowed for the stable expression of the reporter trans-
gene in avian primary erythroid progenitors by
transposition of the Tol2 construct into the cellular
genome.
Characterization of the ΔhCD4 surface marker expression
Although 10% of stably positive cells is a sign of efficient
transgenesis when working on primary cells, it is still rel-
atively low for studying and observing closely the biolog-
ical effect of a given transgene. Such a low percentage ofBMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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cells stably expressing a transgene can be bypassed by
clonal selection when working with immortal cell lines.
This is clearly not the case when working with normal
cells since their lifespan is limited by the so-called "Hay-
flick limit" [24]. For T2EC cells, which can only be grown
for about one month [17], this therefore precludes the use
of multiple successive cloning to generate a pure popula-
tion of cells expressing a transgene of interest. We there-
fore decided to use the MACS-based method, in which
cells carrying the transgene are retained on a magnetic col-
umn (Figure 1B).
Since the ΔhCD4 sequence is carried by the same bicis-
tronic mRNA as the reporter transgene (Figure 1C), the
presence of the ΔhCD4 marker should indicate the pres-
ence of the transgene. In order to confirm this feature in
our experimental model, ΔhCD4 expression, following
different transfection conditions, was quantified using a
fluorochrome-conjugated hCD4 antibody (Figure 4). Ini-
tially, even though ΔhCD4 is not naturally expressed by
T2EC, we observed that a very small percentage of
untransfected cells are positive to ΔhCD4 labeling (2%,
Figure 4A), suggesting that a small fraction of T2EC
expresses a surface protein that cross-reacts with the hCD4
antibody. However, this percentage of false-positive cells
is insignificant compared to the ΔhCD4-positive fraction
of cells within a population transfected with the pT2MIK
empty plasmid (30.4%, Figure 4B) or with the pT2MIK-
eGFP expression plasmid (23.2%, Figure 4C). Further-
more, our data shows that among the eGFP-positive cells
(44.6% of the total population, Figure 4C), approximately
half of them are also ΔhCD4-positive. Indeed, with
respect to the total population, 21% of cells are eGFP-pos-
itive/ΔhCD4-positive and 23.6% are eGFP-positive/
ΔhCD4-negative. If considering the surface marker only,
the latter fraction is composed of false-negative cells. Also,
as expected, it appears that the ΔhCD4 expression level is
correlated to the eGFP expression level and the false-neg-
ative cells correspond to the low-level eGFP-expressing
cells. Whether these cells express the surface marker at an
undetectable level in these conditions or do not express it
at all is, as yet, unresolved. Nevertheless, these observa-
Stable expression of eGFP in the presence of transposase Figure 2
Stable expression of eGFP in the presence of transposase. A: Relative proportion evolution, with respect to time after 
transfection, of eGFP-positive cells within a population of T2EC, either transfected with the pT2MIK-eGFP expression plasmid 
only (eGFP), or cotransfected with the pT2MIK-eGFP plasmid and the transposase expression pCAGGS-T2TP plasmid (eGFP 
+ T) with an equimolar ratio (1/1). Significant differences were determined with a t-Test (n ≥ 3): p = 2.44 × 10-2 (*) and p = 9 × 
10-4 (* *). B: Relative proportion evolution, with respect to time after transfection, of eGFP-positive cells within a population of 
T2EC cotransfected with the pT2MIK-eGFP plasmid (eGFP) and the pCAGGS-T2TP plasmid (T). As indicated in the legend, 
different molecular ratios were tested, pT2MIK-eGFP (7.6 kb)/pCAGGS-T2TP (7 kb): 1/5; 1/1; 5/1 and 10/1, but the amount of 
total DNA (pT2MIK-eGFP + pCAGGS-T2TP) was constant. For one given time point, conditions not connected by the same 
letter are significantly different, p < 0.05 (Tukey-Kramer HSD test, n ≥ 3). Cell fluorescence was analyzed by flow cytometry 
(FACS). The positive fluorescence threshold is fixed in order to have 99% of the negative cells (i.e. cells transfected with the 
empty plasmid) below this threshold. A 1% value is, hence, considered as null.BMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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tions confirm that the pT2MIK-eGFP expression plasmid
allows the expression of the ΔhCD4 surface marker, on
which the magnetic sorting (MACS) depends.
MACS allows for the efficient sorting of eGFP-positive cells
In order to increase the proportion of cells expressing the
transgene of interest with respect to the total transfected
population, we tested the efficacy of the MACS-based
method. As previously observed, in the absence of any
selection (Figure 5, first column: No MACS) the relative
ratio of cells expressing the eGFP reporter gene dropped
rapidly to about 8% and was then stably maintained
(7.6% ± 1.1 and 8.3% ± 0.8 for 7 and 11 days, respec-
tively, post-transfection). Following a single round of sort-
ing (Figure 5, second column: MACS x1), the culture
already contains a significantly higher rate of cells carrying
the transgene in a stable manner. The percentage of eGFP-
positive cells, with respect to the total population, is four
to five times higher than in unsorted cells (38.0% ± 11.2
and 34.4% ± 3.8 at day 7 and 11, respectively). When the
Identification of the Tol2 construct genomic insertion sites on the T2EC clone #1 Figure 3
Identification of the Tol2 construct genomic insertion sites on the T2EC clone #1. A: Splinkerette PCR products 
on 1.5% agar gel. 1: Fermentas DNA Ladder Mix; 2: genomic DNA from non-transfected T2EC; 3: pT2.CMV-hKO plasmid; 4: 
genomic DNA from T2EC clone #1, cotransfected with the pT2.CMV-hKO plasmid and the transposase plasmid, pCAGGS-
T2TP (molecular ratio: 5/1). B: Alignment of the splinkerette PCR product with the Gallus gallus genome. The sequence corre-
sponding to the Tol2 construct is shown in bold. C: Localization of the Tol2 construct insertion site into chromosome 4 of 
the Gallus gallus genome.BMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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sorting is extended to three successive times, the same cul-
ture (Figure 5, fourth column: MACS x3) reaches a relative
ratio of about eight to nine times higher than the non-
sorted culture (72.9% ± 4.9 and 63.5% ± 14.6 at day 7 and
11, respectively). Although at the end of the experiment
the eGFP-positive cell percentage, with respect to the total
population, in the MACSx2 condition (Figure 5, third col-
umn: 48.1% ± 7.2 after 11 days post-transfection) is not
significantly different from both the MACSx1 and the
MACSx3 conditions, it is a necessary transitory step
towards the three times-sorted culture, in which the posi-
tive cell percentage differs significantly from both the
non-sorted and the once sorted cultures.
Thus, the MACS-based technique has enabled us to signif-
icantly enrich a population of transfected primary progen-
itor cells with eGFP-positive cells.
MACS exclusively sorts cells that stably express the 
transgene
In order to assess whether the eGFP-positive cells sorted
after three successive rounds were stably positive cells, we
tested the same protocol of successive rounds of MACS on
a T2EC population transfected with the eGFP expression
plasmid only which, consequently, shows a transient
eGFP expression (Figure 5, italic values). On day 4, with
respect to the length of time following transfection, we
observed that the first two rounds of MACS successfully
sorted eGFP-positive cells in the absence of transposase
and, hence, those transiently expressing the transgene.
This sorting gives a population within which there is a
high percentage of eGFP-positive cells (94.4% and 90.6%
after one and two MACS, respectively). However, between
the fourth and the seventh day which, according to our
previous observations, is the period when the transient
expression is lost and the stably expressing transfectants
emerge (Figure 2A), the percentage of eGFP-positive cells
dropped dramatically to 6.1%. Although the third MACS
separation moderately increases this percentage (to
12.4%), these transient-expressing cells are rapidly lost at
the next point of measurement (1.5%, which virtually
overlaps with the 1% null threshold).
Taken together, our data show that the Tol2 transposition
system can be associated with a MACS-based technique
which significantly improves the stable expression effi-
ciency of the resulting Tol2/MACS system. In fact, this
association significantly increases the proportion of cells
expressing the transgene among the total transfected pop-
ulation.
Discussion
We have described an efficient technique which allows the
selection of the stable integration of an exogenous trans-
gene into the host genome. The importance of this study
is twofold:
1. we have demonstrated that the versatility of the
Tol2 system can be extended to normal chicken eryth-
roid progenitor cells and
2. we have demonstrated the feasibility of combining
this chromosomal integration technique with a MACS
(MAgnetic Cell Sorting)-based enrichment method,
Quantification of the hCD4 marker and the eGFP expression before MACS Figure 4
Quantification of the hCD4 marker and the eGFP expression before MACS. A population of T2EC not transfected 
(A) or transfected with either the pT2MIK empty plasmid (B) or the pT2MIK-eGFP expression plasmid (C) were labeled with 
an APC-conjugated antibody that recognizes the hCD4. Labeled cell fluorescence was analyzed by flow cytometry (FACS) one 
day after transfection. The positive fluorescence threshold is fixed in order to have 99% of the negative cells (i.e. untransfected 
and unlabeled cells) below this threshold. A 1% value is, hence, considered as null.BMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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Enrichment, using MACS, of the transfected population on cells carrying the transgene Figure 5
Enrichment, using MACS, of the transfected population on cells carrying the transgene. Relative ratio evolution of 
eGFP-positive cells within a population of T2EC cotransfected with the eGFP expression plasmid and the transposase-supplier 
helper plasmid (molecular ratio: 5/1). Rows: different time points after transfection (on days), ↓ symbolizes the evolution of the 
culture as a function of time. Columns: Successive MACS: cell cultures were sorted once (MACSx1), twice (MACSx2), three 
times (MACSx3) or not sorted at all (no MACS), → symbolizes the evolution of one culture before and after a sorting. Histo-
grams illustrate the cell number repartition according to the fluorescence intensity, from one single representative experiment. 
Values in bold correspond to the mean ± SD after experiment repetition (n = 4). For the same given time point, conditions 
not connected by the same letter (a, b, c, or d) are significantly different, p < 0.05 (Tukey-Kramer HSD test, n ≥ 3). Values in 
italics correspond to the relative ratio of eGFP-positive cells within a population of T2EC transfected with the eGFP expression 
plasmid only (no transposase) and sorted once, twice, three times or not sorted at all. Cell fluorescence was analyzed by flow 
cytometry (FACS). The positive fluorescence threshold is fixed in order to have 99% of the negative cells (i.e. cells transfected 
with the empty plasmid) below this threshold. A 1% value is, hence, considered as null.BMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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allowing the instantaneous sorting of cells carrying the
transgene.
The value of the Tol2 transposon-derived transgenesis
strategy has been confirmed by reports of its ability to
undergo efficient transposition in a wide variety of verte-
brate species [7-12]. Among the DNA transposable ele-
ments, the Sleeping Beauty transposon, a member of the
mariner family [25], has been previously reported to be
capable of undergoing efficient transposition in chicken
[26]. However, a Sleeping Beauty-based transgenesis sys-
tem was found to be inefficient in primary avian cells,
despite its efficacy when tested on immortalized avian
cells [27]. The present report demonstrates that Tol2, con-
trary to Sleeping Beauty, provides an efficient transgenesis
system in primary avian erythroid progenitors.
Regarding the optimal molecular ratio between the
expression and the helper plasmid, our data suggest that
transposition is more efficient when cells are cotrans-
fected with more of the Tol2 expression plasmid than the
transposase one. This observation seems to indicate that
there is an "overproduction inhibition", which leads to a
decrease in transpositional activity in the presence of an
increased amount of transposase [28]. Nevertheless, it has
recently been reported that the Tol2 transposon-based
system does not exhibit overexpression inhibition within
the tested transposase concentration range [12]. Even if, at
first sight, there seems to be a discrepancy between this
report and our results, there is a subtle experimental dis-
tinction which may explain this difference. In reference
[12], the total amount of DNA was variable. This is in con-
trast with our own study in which we decided to fix the
total DNA amount. The increase in the level of the trans-
posase plasmid was then accompanied by a decrease in
the amount of expression plasmid. Moreover, in our cel-
lular model the efficiency of the Tol2/MACS system is pro-
portional to the quantity of Tol2 expression plasmid
present, as well as the number of cells to be transfected
(see Additional File 3). Therefore, the reason for the
decreased transpositional efficacy observed with the 1/5
ratio is likely to be the decrease in the amount of Tol2
expression plasmid rather than an "overexpression inhibi-
tion".
In our experimental model, we were limited both by a
maximal total of DNA used for the transfection and by the
number of cells to be transfected, since the cell viability
after nucleofection is inversely proportional to these
parameters (see Additional File 3). These features are
inherent to our model (i.e. primary erythroid progenitors
and the nucleofection technique) so, when transferring
the Tol2/MACS method to other cellular models and/or
other transfection techniques, this should be set and opti-
mized in order to take full advantage of this method.
We developed an approach based on the splinkerette tech-
nique [23] that allowed us not only to prove that there is
an integration into the cellular genome, but also to actu-
ally characterize the insertion sites. Our results show that
there is one single insertion point per T2EC clone ana-
lyzed, suggesting that the transposition event is a quite
discrete event which probably leads to only one (or at
most very few) insertion site. The single insertion point is
localized on different chromosomes in the two analyzed
clones. Whether this insertion site localization is random
or whether there are some preferential genomic regions
cannot currently be determined.
In order to obtain a population where a significant pro-
portion (if not all) of the cells express the transgene, it is
necessary to select or sort the transfected cells. When
working on established cell lines, a common method con-
sists of establishing transgenic clones or lines, which can
be time-consuming. Although working ex-vivo with pri-
mary cells allows for more relevant studies (because they
are normal and non-genetically altered cells), the lifespan
of such cells is, by definition, limited. Hence we have cho-
sen the MACS technique as it allows instantaneous enrich-
ment of the population of cells carrying the transgene,
unlike selection-based techniques which are longer and
often introduce a bias due to their high selectivity. For
example, it has been reported that selecting antibiotic-
based agents can alter cellular metabolism genes [29]. Our
data shows that the present MACS-based method leads,
after three successive selections, to a population in which
about 70% of the cells stably express the transgene. Previ-
ous work in the laboratory [30] showed that transitory
transfection of SCA2, a gene involved in the self-renewal
of T2EC, has significant biological effects for up to three
days after transfection. As these progenitors have a rapid
cycle (they divide every 18 hours [17]), the transgene
expression decreases in the whole population. In fact, cells
carrying the transgene are diluted in a population that has
doubled its size four times in three days. Despite this,
three days after SCA2 transfection a significant effect can
still be observed, which demonstrates that this effect can
be detected even if there is only a small fraction of cells
expressing it. Therefore, having 70% of cells expressing
the transgene in a stable manner within the population is
sufficient for carrying out studies on the genetic functions
in these cells.
The efficacy of the MACS system relies upon the expres-
sion of the cell surface marker ΔhCD4, the translation
(and, hence, expression) of which depends on the efficacy
of the IRES. It has been shown that IRES efficiency is lower
than that of the "classic" ribosome entry site (at the mRNA
5' extremity, which drives the cap-dependent translation)
[31]. Characterization of the expression of this marker,
compared with the transgene expression reported by theBMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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eGFP, confirmed this assumption. Therefore, when using
the present method, one should take into account that
about half of the positive cells will actually appear as false-
negatives (i.e., expressing the transgene but not the
marker). Moreover, the expression level of ΔhCD4 is an
important parameter, since the efficacy of positive cell
retention on the magnetic column depends on the
amount of microbead-conjugated antibodies at the cell
surface, which is proportional to the expression level of
this surface marker. In our experiments, the first MACS
selection (leading to almost 100% positive cells) was car-
ried out between 14 and 18 hours after transfection, since
we observed that a MACS cell sorting performed more
than 24 hours later was remarkably less efficient (data not
shown). Timing is, therefore, an important parameter
since we observed that the earlier the selection is done, the
higher the expression level is and, consequently, the
higher the efficiency. According to these observations, it is
tempting to argue that the time point we use is so rapid
that we are likely not to select stable integration events.
However, our data shows that even if the first two MACS
rounds of separation are equally efficient on cells express-
ing the transgene stably or transiently (with or without
transposase), the third one is only efficient when cells are
cotransfected with transposase and, hence, stably express
the transgene. This suggests that these first two MACS
selections are needed to increase both the proportion of
cells expressing the transgene and the expression level of
the ΔhCD4 surface marker in order to increase the efficacy
of the third, and last, MACS separation, which is in fact
the most decisive.
Furthermore, the fact that cells transfected with the empty
plasmid also express the ΔhCD4 marker shows that the
absence of a gene cloned upstream of the IRES does not
impair its expression. This is an important feature since, in
functional studies based on transgene expression, the neg-
ative control is often the condition transfected with the
same empty plasmid. Therefore, the present strategy
allows the sorting of cells transfected with the empty plas-
mid in the same way as cells transfected with the trans-
gene-containing plasmid and, hence, provides a pertinent
minus control. We also observed that, even though it is
marginal, there is a small fraction of cells that would
appear as false-positives and could, therefore, be selected.
This may explain, at least partially, the fact that after each
MACS step there is always a fraction of negative cells
remaining (not expressing the transgene). However, this
could also be explained by the extinction of the transgene
expression. As both the IRES efficacy and the specificity of
labeling with the microbeads-conjugated antibodies
depend on the cell type, this should be tested in a prelim-
inary experiment when transferring the current method to
another experimental model.
According to the ΔhCD4 expression data, it is tempting to
suppose that FACS (Fluorescence-Activated Cell Sorting
([32]) is much more efficient than MACS, but even if there
is a difference in performance it is not particularly striking.
Supposing the same method was adapted to FACS (i.e.
with a fluorescent reporter gene downstream of the IRES
instead of the ΔhCD4), there would also be a fraction of
false-negative cells since the level of reporter gene expres-
sion depends on the efficiency of the IRES. Therefore, the
proportion of true-positive cells (i.e., expressing the trans-
gene and the reporter fluorescent gene) would not be very
different from the one observed with the ΔhCD4, which is
about 20% in T2EC. In practice, for MACS, we determined
in our experimental model that up to 10% of the cells are
actually sorted (see Additional File 4) This observation
suggests that among the 20% of cells expressing the
ΔhCD4, the magnetic column will actually retain only
half. FACS is based on optical properties detected by an
instrument, whereas MACS depends on several physical
interactions (ΔhCD4 marker/antibody/magnetic col-
umn), so it is possible that FACS would have a higher sen-
sitivity and this could increase the percentage of sorted
cells up to 20%.
Nevertheless, if this constitutes an obvious advantage of
FACS over MACS, there are also many advantages of
MACS over FACS. First of all, FACS requires the expression
of a fluorescent reporter gene, which is generally present
in the cytoplasm. The expression of the MACS-required
ΔhCD4, which is only at the cell surface without any cyto-
plasmic region present (as it has been deleted), is there-
fore more confined and more silent as regards cell
function. Also, the antibody-conjugated microbeads are
ultrasmall (approx. 50 nm ∅), biodegradable, and non-
toxic to cells. Thus, transfected cells are magnetically
selected without affecting cell function or viability. Fur-
thermore, from a purely practical point of view, the MACS
technique and equipment are more accessible than those
used for FACS. In fact, FACS requires the appropriate
sorter, an instrument that may not be available in the lab-
oratory. On the other hand, the MACS equipment is very
simple: the magnetic sorter can be placed on the lab
bench as it is as easy to handle as a normal test tube rack.
Moreover, whereas FACS selection can be time-consum-
ing, since it sorts cell by cell, with a MACS experiment it is
possible to instantly sort up to 107 positive cells, within 2
× 108 cells per column, in about one hour (including the
labeling and wash steps), with the column version used in
our experiment. For cells which have a reduced viability
outside of the incubator, this could make a huge differ-
ence. In addition, it is possible to work with several col-
umns at the same time, or to work with high capacity
columns (up to 108 positive-cells within 2 × 109 cells per
column).BMC Biotechnology 2009, 9:81 http://www.biomedcentral.com/1472-6750/9/81
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However, it is important to note that our system is com-
patible with a Tol2/FACS variant. Instead of using the
microbead-conjugated antibody and a magnetic column,
it is possible to use a fluorochrome-conjugated hCD4
antibody (equivalent to the one used to characterize the
expression of the ΔhCD4 in this study) to label the cells
carrying the transgene and then sort these cells according
to their fluorescence.
The MACS technique provides an efficient, rapid, gentle
and easy way to sort cells, but methodological improve-
ments could still be made. We believe that since the effi-
ciency of the IRES-based expression might be
questionable (see above), the priority is to develop an
alternative Tol2/MACS system without the drawbacks of
the IRES. We are, therefore, currently designing a Tol2
construct with two genes (the one of interest and the
ΔhCD4-coding sequence) driven by two different promot-
ers, leading to higher expression on the ΔhCD4 and,
hence, a higher MACS efficiency. However, it is known
that constitutive and highly active promoters can mutu-
ally interfere with each others functioning [4]. This is why
it seems relevant to add, between the transgene and the
sorting gene, an insulator [33] to block any interference
between the two promoters. The functional analysis of
such a construct is, however, beyond the objectives of the
current study.
It is, therefore, expected that further improvements can be
made to extend the versatility of this stable expression
strategy, combined with the simple and efficient MACS
method. This strategy will then allow a genetic manipula-
tion of target cells/tissues in a wide range of cell types and
species. Moreover, this strategy is perfectly suited for pri-
mary cells, which are non-immortalized and often deli-
cate, and, more generally, in all cases when time becomes
a critical parameter.
Conclusion
We have described a new Tol2/MACS selection system
that leads to stable expression in a culture of primary
chicken erythroid cells highly enriched in cells expressing
the transgene of interest. This system could be used in a
wide variety of vertebrate species and is perfectly suited for
primary cells, which are often delicate, and, more gener-
ally, in all cases when time becomes a critical parameter.
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